Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              Siponimod Stabilizes Physical Disability Scores in People Living With Secondary Progressive Multiple Sclerosis After 2 Years of Treatment: Analysis From the Novartis Global Managed Access Program

              Author:Cox, Gina Mavrikis   De Las Heras, Virginia   Ryan, Suzannah   Istrate, Roxana Oana   Ansari, Soudeh   Arnould, Sophie   Piani-Meier, Daniela   

              Session Name:P8: MS Therapeutics 2  

              Topic:MS and Inflammatory Disease  

              Program Number:P8.010  

              Author Institution:Novartis Pharmaceuticals Corporation, East Hanover, NJ  Novartis Pharma AG, Basel, Switzerland  

              Audit of Guidance on Contraceptive Measures and Folic Acid Supplementation in Women with Epilepsy

              Author:Feeney, Emily   Gander, Lara   Doherty, Colin   

              Session Name:P8: Epilepsy/Clinical Neurophysiology (EEG): Women with Epilepsy 1  

              Topic:Epilepsy/Clinical Neurophysiology (EEG)  

              Program Number:P8.010  

              Author Institution:St. James's Hospital, Dublin, Ireland  

              A Phase 2, Randomized, Placebo-Controlled Trial to Evaluate the Effects of SAGE-718 in Patients with Alzheimer's Disease: Study Design

              Author:Lago, Tiffany   Koenig, Aaron   Johannesen, Jason   Park, Sola   Li, Sigui   Freitag, Emily   Wald, Jeffrey   Paumier, Katrina   Quirk, Michael   Doherty, James   

              Session Name:P8: Aging and Dementia: Therapeutics 2  

              Topic:Aging and Dementia  

              Program Number:P8.010  

              Author Institution:Sage Therapeutics, Inc., Cambridge, MA